Two Maine biotech companies have announced news regarding recent changes, Portland Press Herald reports. Scarborough based Fluid Imaging Technologies, BAM member and developer of a specialized device which allows for viewing particles in fluid, just introduced the expansion of their highly popular product, FlowCam, in the 50th country, giving the company a footprint in 7 continents. Shifting gears, another biotech startup company, Biovation of Boothbay is closing its doors. After seven years of developing and marketing innovative anti-microbial fiber products, the startup has laid off employees and put its assets up for sale. “With any risk comes the possibility of failure” said Biovation’s CEO Kerem Durdag about the recent development “It is my strongest belief that we as a state have to culturally get comfortable with the idea of risk if we are to be economically viable and have multiplier (effects) for our kids. And hence we have to see the value of failure. We just have to.” Read full article
Related Posts
Maine’s first mobile biolab starts tour of rural schools in Fort Kent
FORT KENT, Maine — Fort Kent middle schoolers are the state’s first students to learn at the newly unveiled Maine Mobile Biolab, a 50-foot,...
UMaine Augusta’s $1.75M medical lab training facility doubles student capacity
Anew medical lab training facility on the campus of University of Maine Augusta is nearly six times larger than an off-campus space...
UNE receives grant to research state-threatened animal
The University of New England has received a grant from the Maine Department of Inland Fisheries and Wildlife to study one...